Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Amoxicillin
Cross Vetpharm Group Ltd
QJ01CA04
Amoxicillin
Expired
Revised: December 2010 AN: 01370/2010 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Amoxyvet 250mg Hard Capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains: Active ingredient mg per capsule Amoxicillin 250 (as Amoxicillin trihydrate) Capsule Body: Erythrosin (E127) 0.0011 Quinoline yellow (E104) 0.00329 Titanium dioxide (E171) 0.48311 Capsule Cap: Erythrosin (E127) 0.549 Ferric oxide red (E172) 0.244 Titanium dioxide (E171) 0.1952 Ink: Black iron oxide (E172) For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Capsules, hard Red and white, hard capsules with the logo ‘AMX/250’ in black ink 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs Page 1 of 6 Revised: December 2010 AN: 01370/2010 4.2 INDICATIONS FOR USE Amoxyvet Hard Capsules are indicated in the treatment and control of diseases cause by or associated with bacterial pathogens sensitive to amoxicillin. These include the following groups of pathogens: _Pasturella spp._ _Staphylococci_ (penicillin sensitive strains) _Streptococci_ When susceptible organisms are present, treatment with Amoxyvet Hard Capsules may be effective in the following indications: Localised infections Alimentary tract infections Respiratory infections Urogenital tract infections Secondary bacterial infections General infections 4.3 CONTRAINDICATIONS Not to be administered to animals known to be sensitive to penicillin. Do not treat dogs of less than 10kg bodyweight. Not to be administered to small herbivores. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None 4.5 SPECIAL PRECAUTIONS FOR USE, INCLUDING SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE MEDICINAL PRODUCT TO THE ANIMALS i. Specials precautions for use in animals Whenever possible, the Amoxyvet Hard Capsules should Read the complete document